Biogen Inc vs DigitalOcean Holdings Inc — how do they compare? Biogen Inc trades at $203.5 (market cap $30.13B), while DigitalOcean Holdings Inc trades at $124 (market cap $14.21B). The key difference: Biogen Inc is far larger — about 2.1× DigitalOcean Holdings Inc's market cap, and Biogen Inc is trading nearer its 52-week high, DigitalOcean Holdings Inc nearer its low. Which is the better fit depends on your goals.
| BIIB | DOCN | |
|---|---|---|
Market Cap | $30.13B | $14.21B |
Sector | Health | Technology |
52-Week High | $216.63 | $181.29 |
52-Week Low | $128.93 | $29.99 |
Enterprise Value | $37.20B | $14.97B |
Trailing returns across standard periods
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →